We must protect our girls from the CDC

When the mom of a 15-year-old Indiana teen saw the Merck “One Less” campaign, she made sure her daughter Maddie got vaccinated with Gardasil.

After the first dose, Maddie started having pain and fatigue.

After the second one, she was in such bad shape she couldn’t even go to school.

Her mom now says that she wishes she could have “a do-over,” in deciding to have Maddie get the shot.

But she’s just one of over 31,000 young girls who have sent in reports to the FDA about adverse Gardasil vaccine reactions.

Those reports include cases of seizures, paralysis…and death.

And all the while the CDC continues to say the vaccine is safe. And it does that in a very clever way — one that is pure marketing genius.

Because when you hear these assurances, you’ll never realize that Big Pharma’s PR department is the CDC.

Whenever you see a CDC official interviewed or quoted regarding a vaccine — ANY vaccine — you may be surprised to learn that you’re actually watching an advertisement.

It doesn’t look like an ad. You won’t see pretty models or a clever slogan. And, of course, there are no disclaimers.

Instead, there’s a government official “educating” the unwary on why they should trust the CDC’s judgment and blindly roll up their sleeves for whatever vaccines it endorses.

There’s just one problem. The CDC’s recommendations are driven by sales, not science.

Today, the marketing lesson is on ‘how to sell HPV vaccines to a skeptical crowd’.

Because there’s a new version of Gardasil coming down the pike. It’s an even stronger and probably riskier version than the original. And this vaccine, currently called V503, is now being concocted in Merck’s laboratories.

Merck hopes to have V503 on the market ASAP. That’s why the CDC is doing all it can to promote these kinds of vaccines — to keep people from ‘wising up’ to the danger, like Maddie’s mom belatedly did.

Recently, the CDC conducted a study to assess effectiveness of HPV vaccines. The study included subjects vaccinated with Gardasil (Merck’s vaccine) and Cervarix (GlaxoSmithKline’s vaccine).

My! That was awfully good of the CDC to spend OUR tax dollars to help Merck and GSK do the work THEY should be paying for!

And that wasn’t the only gift the CDC gave to the drug giants.

The CDC announced the good news results in a press release with this headline… “New study shows HPV vaccine helping lower HPV infection rates in teen girls.”

Fantastic! Right? The vaccines work! Our girls are safe!

Well…not exactly.

An oncology dietician named Sharlene Bidini analyzed the study. With a sharp eye for detail, she uncovered stunning results. They’re right there for anyone to see. But the CDC clearly does not want to highlight them in its marketing strategy.

For instance, the study examined HPV exams from more than 8,000 women. But some of them were as old as 59! And less than 10 percent (only 740) were actually teens.

Suddenly, this large study looks pretty thin. But it gets even thinner.

Of those 740 teens, only 358 were sexually active. So for 382 teens, the testing was irrelevant. Their likelihood of having HPV was zilch!

And now here’s the kicker. Among the 358 sexually active teens, just 111 received at least one dose of the three-dose vaccine.

Doctors have given millions of girls these vaccines. And the sample the CDC came up with was barely more than 100? And those didn’t even necessarily go through the whole treatment?

But here’s the real kicker:

Over the study period, occurrence of HPV infection dropped by less than 6 percent among vaccinated teens. In unvaccinated teens, HPV dropped by more than 27 percent.

So maybe that headline should have read: “Unvaccinated girls safer than vaccinated girls.”

But of course, the CDC and its Big Pharma brethren aren’t going to sell any vaccines with THAT headline.

So ask yourself…what would Don Draper do?

Sources:
“Gardasil: Mother wants answers after daughter’s HPV vaccine reaction” Melissa Yeager, April 7, 2014, WCPO, theindychannel.com

“Merck’s experimental HPV vaccine shows promise in late-stage trial” Peter Loftus, November 3, 2013, The Wall Street Journal, online.wsj.com

“New study shows HPV vaccine helping lower HPV infection rates in teen girls” CDC Press Release, 6/19/13, cdc.gov

“Assessing the Overall Impact of the HPV Vaccine” Sharlene Bidini, RD, CSO, The ONC, 7/1/13, theonc.org